Patent details

EP2670753 Title: NOVEL HETEROCYCLIC DERIVATIVES

Basic Information

Publication number:
EP2670753
PCT Application Number:
PCT/IB/2012/050428
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127041358
PCT Publication Number:
WO/2012/104776
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL HETEROCYCLIC DERIVATIVES
French Title of Invention:
DÉRIVÉS HÉTÉROCYCLIQUES INÉDITS
German Title of Invention:
NEUE HETEROCYCLISCHE DERIVATE
SPC Number:

Dates

Filing date:
30/01/2012
Grant date:
19/10/2016
EP Publication Date:
19/10/2016
PCT Publication Date:
09/08/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/12/2013
EP B1 Publication Date:
19/10/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/01/2017
Expiration date:
30/01/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/01/2012
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
ZHU Yanyi
Address:
United States (US)

2

Name:
RADETICH Branko
Address:
United States (US)

3

Name:
YU Bing
Address:
United States (US)

Priority

1

Priority Number:
201161437956
Priority Date:
31/01/2011
Priority Country:
United States (US)

2

Priority Number:
201161552905
Priority Date:
28/10/2011
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 487/04;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages